PEP035

Invitrogen™ Human Myc Tag (aa 410-419) Synthetic Peptide

Manufacturer: Invitrogen™

Select a Size

Pack Size SKU Availability Price
Each of 1 PEP035-Each-of-1 In Stock ₹ 15,640.37

PEP035 - Each of 1

₹ 15,640.37

In Stock

Quantity

1

Base Price: ₹ 15,640.37

GST (18%): ₹ 2,815.267

Total Price: ₹ 18,455.637

Gene ID (Entrez)

4609

Purification Method

purified

Common Name

Human Myc Tag (aa 410-419)

Content And Storage

-20°C. Avoid freeze-thaw cycles.

Format

Lyophilized

For Use With (Application)

Control

Lyophilized

Yes

Product Type

Peptide

Regulatory Status

RUO - research use only

Species

Human

Accession Number

P01106

Concentration

0.5 mg/mL

Description

Synthetic Peptide

Formulation

peptide with no preservative

Gene Symbol

MYC

Preservative

No preservative

Quantity

50 μg

Sequence

(C) - E410 - Q - K - L - I - S - E - E - D - L419

Related Products

Img

Thermo Scientific

PEP253

--

Img

Thermo Scientific

PEP232

--

Img

Invitrogen™

PEP067

--

Img

Thermo Scientific

PEP154

--

Img

Thermo Scientific

PEP070

--

Img

Thermo Scientific

PEP130

--

Img

Invitrogen™

ABCB86

--

Img

Thermo Scientific

PEP148

--

Description

  • Human C-Myc (residues 410-419) Synthetic Peptide, PEP-035, from Invitrogen
  • The c-Myc protein is a 62 kDa transcription factor that is encoded by the c-Myc gene on human chromosome 8q24
  • c-Myc is commonly activated in a variety of tumor cells and plays an important role in cellular proliferation, differentiation, apoptosis and cell cycle progression
  • The phosphorylation of c-Myc has been investigated and previous studies have suggested a functional association between phosphorylation at Thr58/Ser62 by glycogen synthase kinase 3, cyclin dependent kinase, ERK2 and C-Jun N terminal Kinase (JNK) in cell proliferation and cell cycle regulation
  • Studies have shown that c-Myc is essential for vasculogenesis and angiogenesis in tumor development, which distributes blood throughout the cells
  • The c-myc oncogene (p62 c-myc) is involved in the control of normal cellular proliferation and differentiation, and the deregulated expression of c-Myc induces apoptosis in different cell types
  • Antibodies against c-myc epitopes recognize overexpressed proteins containing Myc epitope tag fused to either amino- or carboxy-termini of targeted proteins
  • c-Myc-, N-Myc- and L-Myc-encoded proteins function in cell proliferation, differentiation and neoplastic disease
  • Amplification of the c-Myc gene has been found in several types of human tumors including lung, breast and colon carcinomas, while the N-Myc gene has been found amplified in neuroblastomas
  • Translocation of the c-myc locus on chromosome 8 to the immunoglobulin loci on chromosome 14 (heavy chain); 2 (delta light chain); or 22 (light chain) is described in Burkitts lymphoma and other B-cell lymphoproliferative conditions
  • An aberrant expression of the c-myc gene occurs in tumors of different origins such as colorectal, gastric, gallbladder, hepatic, mammary, ovarian, endometrial, head and neck, pulmonary, prostatic, thyroidal, oral, ocular, nasopharyngeal, endocrine, as well as hematopoietic neoplasms
  • PEP-035 is an 11 amino acid synthetic peptide whose sequence corresponds to amino acid residues 410-419 of human c-Myc
  • The sequence of this peptide is (amino to carboxy terminus): (C)-E410-Q-K-L-I-S-E-E-D-L419 (A Cysteine residue was added to the amino terminal to facilitate coupling KLH).This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and the cMyc epitope tag, catalog &Num PA1-981
  • Using a solution with equal weights per unit volume of peptide and corresponding antibody will yield a solution with a large molar excess of peptide that is able to competitively bind the antibody.Reconstitute with 0.1 mL of distilled water.